175 related articles for article (PubMed ID: 22454562)
1. Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Smeland E; Kilvaer TK; Sorbye S; Valkov A; Andersen S; Bremnes RM; Busund LT; Donnem T
Sarcoma; 2012; 2012():541650. PubMed ID: 22454562
[TBL] [Abstract][Full Text] [Related]
2. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.
Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
BMC Clin Pathol; 2012 May; 12():7. PubMed ID: 22554285
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas.
Valkov A; Sorbye S; Kilvaer TK; Donnem T; Smeland E; Bremnes RM; Busund LT
Int J Oncol; 2011 Apr; 38(4):1031-40. PubMed ID: 21271213
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.
Valkov A; Sorbye SW; Kilvaer TK; Donnem T; Smeland E; Bremnes RM; Busund LT
PLoS One; 2011 Mar; 6(3):e17507. PubMed ID: 21390241
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.
Valkov A; Kilvaer TK; Sorbye SW; Donnem T; Smeland E; Bremnes RM; Busund LT
J Transl Med; 2011 Nov; 9():200. PubMed ID: 22107784
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma.
Kim JI; Choi KU; Lee IS; Choi YJ; Kim WT; Shin DH; Kim K; Lee JH; Kim JY; Sol MY
Oncol Lett; 2015 Apr; 9(4):1699-1706. PubMed ID: 25789026
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.
Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
BMC Clin Pathol; 2013 Mar; 13():9. PubMed ID: 23497154
[TBL] [Abstract][Full Text] [Related]
9. Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
Kilvaer TK; Valkov A; Sorbye S; Smeland E; Bremnes RM; Busund LT; Donnem T
PLoS One; 2010 Dec; 5(12):e15368. PubMed ID: 21179485
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of lymphocytes in soft tissue sarcomas.
Sorbye SW; Kilvaer T; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
PLoS One; 2011 Jan; 6(1):e14611. PubMed ID: 21298041
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
Kilvaer TK; Valkov A; Sorbye SW; Smeland E; Bremnes RM; Busund LT; Donnem T
J Transl Med; 2011 Jul; 9():104. PubMed ID: 21733164
[TBL] [Abstract][Full Text] [Related]
13. The expression of metabolism-related proteins in phyllodes tumors.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.
Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
BMC Clin Pathol; 2012 Feb; 12():5. PubMed ID: 22375962
[TBL] [Abstract][Full Text] [Related]
15. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
[TBL] [Abstract][Full Text] [Related]
16. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.
Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P
Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082
[TBL] [Abstract][Full Text] [Related]
17. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
19. Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival.
Kilvaer TK; Valkov A; Sorbye SW; Donnem T; Smeland E; Bremnes RM; Busund LT
Sarcoma; 2010; 2010():751304. PubMed ID: 21331156
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.
Boström PJ; Thoms J; Sykes J; Ahmed O; Evans A; van Rhijn BW; Mirtti T; Stakhovskyi O; Laato M; Margel D; Pintilie M; Kuk C; Milosevic M; Zlotta AR; Bristow RG
Bladder Cancer; 2016 Jan; 2(1):101-109. PubMed ID: 27376131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
